Compositions for treating or preventing pain

Abstract

The present disclosure is directed to compositions comprising 4-({(4-cyclopropylisoquinolin-3-yl)[4-(trifluoromethoxy)benzyl]amino}sulfonyl) benzoic acid, or a pharmaceutically acceptable salt thereof, for treating or preventing pain, for example migraine, in a subject, and methods which comprises administering the said compound, or the pharmaceutically acceptable salt thereof, respectively.